Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPS1 | P31327 | 6/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.41 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.41 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.41 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.41 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.41 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.41 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.41 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.41 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.41 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29904242 | 1.00 | CPS1 (0.49) | CPS1CA1CA2ENPP2CYP1A2 | |
| SCHEMBL257633 | 0.88 | SMN1; SMN2 (0.51) | CPS1ENPP2KDM4ESMN1; SMN2 | |
| SCHEMBL14634405 | 0.85 | NPC1 (0.47) | CA1CA2ENPP2SMN1; SMN2 | |
| SCHEMBL931782 | 0.83 | CA1 (0.48) | CPS1CA1CA2ENPP2CYP1A2 | |
| SCHEMBL29454619 | 0.83 | CA1 (0.48) | CPS1CA1CA2ENPP2CYP1A2 | |
| SCHEMBL258021 | 0.80 | SOS1 (0.46) | CA1CA2 | |
| SCHEMBL10269426 | 0.79 | ENPP2 (0.44) | ENPP2 | |
| SCHEMBL29636290 | 0.79 | ALDH1A1 (0.44) | CPS1MEN1ALDH1A1GAAKMT2A | |
| SCHEMBL3851173 | 0.79 | PDE2A (0.44) | MAPT | |
| SCHEMBL20659060 | 0.79 | ALDH1A1 (0.44) | CPS1MEN1ALDH1A1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111978331-B | Preparation method of FLT3 and FGFR kinase inhibitor | 上海再极医药科技有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-115417817-A | Preparation method of 4-amino-4-phenylisoquinoline-1,3-diketone derivative | 徐州医科大学 | 2022-12-02 | — | — | CN | claimed |
| CN-111978331-A | Preparation method of FLT3 and FGFR kinase inhibitor | 上海再极医药科技有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-105330642-A | Selenophen compound | INOR WUHAN PHARMACEUTICAL CO LTD | 2016-02-17 | — | — | CN | claimed |
| CN-122055371-A | Faster automated iterative C-C bond formation | 伊利诺伊大学评议会 | 2026-05-15 | — | — | CN | disclosed |
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | GIVAUDAN SA (CH) | 2026-04-16 | — | — | US | disclosed |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2026-04-02 | — | — | US | disclosed |
| EP-4482583-B1 | ZWITTERIONIC ANTIBACTERIAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2026-04-01 | — | — | EP | disclosed |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | GIVAUDAN SA (CH) | 2026-01-20 | — | — | US | disclosed |
| US-20250368605-A1 | Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof | SANOFI (FR) | 2025-12-04 | — | — | US | disclosed |
| US-20250340562-A1 | CHROMANE IMAGING LIGANDS | MASSACHUSETTS GEN HOSPITAL (US) | 2025-11-06 | — | — | US | disclosed |
| US-20250340563-A1 | FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS | TAKEDA DEVELOPMENT CENTER AMERICAS, INC. | 2025-11-06 | — | — | US | disclosed |
| US-6010981-A | 1-alkyl-4-benzoyl-5-hydroxypyrazole compounds and their use as herbicides | DOW AGROSCIENCES LLC (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0914317-A2 | 1-ALKYL-4-BENZOYL-5-HYDROXYPYRAZOLE COMPOUNDS AND THEIR USE AS HERBICIDES | Dow AgroSciences LLC (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998052926-A2 | 1-ALKYL-4-BENZOYL-5-HYDROXYPYRAZOLE COMPOUNDS AND THEIR USE AS HERBICIDES | DOW AGROSCIENCES LLC (US) | 1998-11-26 | — | — | WO | disclosed |
| WO-1998007720-A1 | SUBSTITUTED 2-ARYLPYRIDINE AS HERBICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1998-02-26 | — | — | WO | disclosed |
| US-5714087-A | CONTAINING LIQUID CRYSTAL MIXTURE OF SPECIFIED COMPONENTS INCLUDING OPTICALLY ACTIVE COMPONENT | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1998-02-03 | — | — | US | disclosed |
| EP-0713515-B1 | SUPERTWIST LIQUID-CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 1997-11-26 | — | — | EP | disclosed |
| EP-0713515-A1 | SUPERTWIST LIQUID-CRYSTAL DISPLAY | MERCK PATENT GmbH (DE) | 1996-05-29 | — | — | EP | disclosed |
| WO-1995004789-A1 | SUPERTWIST LIQUID-CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 1995-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103459-A1 | SUBSTITUTED AZACYLES AS TRPM8 MODULATORS | TRPM8, TRPM7, TRPM5 | CPS1 1652/4885CA1 739/4885CA2 184/4885 |
| US-20250368605-A1 | Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof | CYP19A1, ESR1, ESR2 | CPS1 2797/4885CA1 1947/4885CA2 3145/4885 |
| US-20250340562-A1 | CHROMANE IMAGING LIGANDS | GRM2, GRM1, GRIA2 | CPS1 3291/4885CA1 1221/4885CA2 1207/4885 |
| US-20260092045-A1 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | TFPI, F3, BTK | CPS1 2874/4885CA1 4145/4885CA2 2474/4885 |
| US-12528801-B2 | Substituted azacyles as TRPM8 modulators | TRPM8, TRPM7, TRPM4 | CPS1 2743/4885CA1 785/4885CA2 240/4885 |
| US-20250340563-A1 | FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS | NLRP3, NLRP1, NOD1 | CPS1 4621/4885CA1 4754/4885CA2 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.